Papillomaviruses in non-melanoma skin cancer: Epidemiological aspects

Seminars in Cancer Biology

Volumn 9, Issue 6, 1999, Pages 397-403

  Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Epidemiology; Non melanoma skin cancer; Papillomavirus

Indexed keywords

CAPSID PROTEIN; GENE PRODUCT; PROTEIN P53; RETINOBLASTOMA PROTEIN; UBIQUITIN;

BASAL CELL CARCINOMA; CANCER MORTALITY; CAUCASIAN; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE MUTATION; HUMAN; PAPILLOMA VIRUS; REVIEW; RISK FACTOR; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION;

EID: 0033503596     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0143     Document Type: Article

References (87)

1. Preston DS, Stern RS. Non-melanoma cancers of the skin. New Engl J Med. 327:1992;1649-1662.
2. Rees J. Genetic alterations in non-melanoma skin cancer. J Invest Dermatol. 103:1994;747-750.
3. Gloster HM, Brodland GC. The epidemiology of skin cancer. Dermatol Surg. 22:1996;217-226.
4. Scotto J, Fears T, Fraumeni J. Incidence of Non-melanoma Skin Cancer in the United States. 1981;Department of Health and Human Services, Washington
5. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J. 296:1988;13-17.
6. Kricker A, Armstrong BK, English DR. Sun exposure and non melanocytic skin cancer. Cancer Causes Control. 5:1994;367-392.
7. Scotto J, Fears TR, Fraumeni JF. Incidence of Non-melanoma Skin Cancer in the United States NIH. 1983;Government Printing Office, Washington
8. Miller DL, Weinstock MA. Non-melanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 30:1994;774-778.
9. Glass AF, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. J Am Med Assoc. 262:1989;2097-2100.
10. Weinstock MA. The epidemic of squamous cell carcinoma. J Am Med Assoc. 262:1989;2138-2140.
11. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer. 81:1999;555-559.
12. Scotto J, Fears T, Fraumeni J. Incidence of Non-melanoma Skin Cancer in the United States. 1981;Department of Health and Human Services, Washington
13. Gallagher RP, Ma B, McLean DI, Yang CP, Ho V, Carruthers JA, Warshawski LM. Trends in basal cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol. 23:1990;413-421.
14. Gray DT, Suman VJ, Su D, Clay RP, Harmsen WS, Randall KR. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol. 133:1997;735-740.
15. Levi F, Franceschi S, Te VC, Randimbison L, La Vecchia C. Trends of skin cancer in the Canton of Vaud, 1976-92. Br J Cancer. 72:1995;1047-1053.
16. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? In J Cancer. 78: 1998;144-148.
17. Kricker A, Armstrong BK, Jones ME, Burton RC. International Research Programme on Health, Solar UV Radiation and Environmental Change. IARC Tech. 1993.
18. Weinstock MA. Non-melanoma skin cancer mortality in the United States. 1969 through 1988. Arch Dermatol. 129:1993;1286-1290.
19. Siverberg E, Boring CC, Squires TS. Cancer statistics. CA. 40:1990;9-26.
20. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 26:1992;976-990.
21. Armstrong BK, Kricker A. Skin cancer. Dermatoepidemiology. 13:1995;583.
22. Stern RS, Weinstein MC, Baker SG. Risk reduction for non-melanoma skin cancer with childhood sunscreen use. Arch Dermatol. 122:1986;537-545.
23. Van der Jeun JC. UV radiation from sunlight: summary, conclusions and recommendations. J Photochem Photobiol B. 35:1996;237-244.
24. De Gruijl FR, van der Leun JC. Urbach P,. Action Spectra for Carcinogenesis. 1992;90-96 Valdenmar Press, KS.
25. Romerdahl CA, Kripke ML. Advances in the immunobiology of the skin. Implications for cutaneous malignancies. Cancer Metastasis Rev. 5:1986;167-178.
26. Gafa L, Filippazzo MG, Tumino R, Dardanoni G, Lanzarone F, Dardanoni L. Risk factors of non-melanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control. 2:1991;395-339.
27. Diffey B. Stratospheric ozone depletion and the risk of non-melanoma skin cancer in a British population. Phys Med Biol. 37:1992;2267-2279.
28. English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer. 77:1998;347-353.
29. International Agency for Research on Cancer. Solar, Ultraviolet Radiation. IARC Monographs. Eval Carcinog Risks Hunman: 55:1992.
30. Queille S, Seite S, Tison S, Mediasko C, Drougard C, Fourtanier A, Sarasin A, Daya Grosjean. L p53 mutations in cutaneous lesions induced in the hairless mouse by a sola 34r ultraviolet light simulator. Mol Carcinog. 22:1998;167-174.
31. Shumrick KA, Coldiron B. Genetic syndromes associated with skin cancer. Otolaryngol Clin North Am. 26:1993;117-131.
32. Leffell DJ, Brash DE. Sunlight and skin cancer. Sci Am. 275:1996;52.
33. Kress S, Sutter CH, Strickland P, Mukhtar H, Schweizer J, Schwarz M. Carcinogen specific mutational pattern in the p53 gene in UVB radiation induced squamous cell carcinomas of mouse skin. Cancer Res. 42:1992;6400-6403.
34. Kanjilal S, Pierceall W, cummings K, Dripke M, Ananthaswamy H. High frequency of p53 mutation in UV radiation induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res. 53:1993;2961-2964.
35. Jiang W, Ananthawswamy HN, Muller HK, Kripke ML. p53 protects against skin cancer induction by UV-B radiation. Oncogene. 29:1999;4247-4253.
36. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res. 52:1992;3804-3806.
37. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE. Mutation hotspots due to sunlight in the p53 gene of non-melanoma skin cancers. Proc Natl Acad Sci USA. 90:1993;4216-4220.
38. van der Riet P, Karp D, Farmer E, Wei Q, Grossman L, Tokino K, Ruppert JM, Sidransky D. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res. 54:1994;25-27.
39. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations insquamous cell carcinoma. Proc Natl Acad Sci USA. 88:1991;10124-10128.
40. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstron Yamasaki H. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA. 91:1994;360-364.
41. Ren ZP, Ahmadian A, Ponten F, Nister M, Berg C, Lundeberg J, Uhlen M, Ponten J. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am J Pathol. 150:1997;1791-1803.
42. Ren ZP, Hedrum A, Ponten F, Nister M, Ahmadian A, Lundeberg J, Uhlen M, Ponten J. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene. 12:1996;765-773.
43. Orth G. Epiderodysplasia verruciformis, Salzman NP, Howley PM. The Papovaviridae, 1987;The Papillomaviruses, New York.
44. Yutsudo M, Tanigaki T, Kanda R, Sasagawa T, Inoue T, Jing P, Yong-Il H, Hakura A. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis. J Clin Microbiol. 32:1994;1076-1078.
45. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papilloma viruses. Ciba Found Symp. 120:1986;157-174.
46. Fuchs PG, Pfister H. Papillomaviruses in epidermodysplasia verruciformis. Papillomavirus Rep. 1:1990;1-4.
47. Pfister H. Human papillomaviruses and skin cancer. Semin Cancer Biol. 3:1992;263-271.
48. Leigh IM, Glover MT. Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res. 139:1995;69-86.
49. London NJ, Armery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet. 8976:1995;346-:714.
50. Lutzner MA, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol. 75:1980;353-356.
51. Van der Leest RJ, Zachow KR, Ostrow RS, Bender M, Pass F, Faras AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol. 123:1987;354-357.
52. Barr BB, Benton EC, McLaren KM, Bunney MH, Smith IW, Blessing K, Hunter JAA. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet i: 1989;124-129.
53. Rudlinger R, Grob R. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet i: 1989;1132-1133.
54. Dyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci. 2:1991;139-146.
55. Soler C, Chardonnet Y, Euvrard S, chignol MC, Thivolet J. Evaluation of human papillomavirus type 5 on frozen sections of multiple lesions from transplant recipients with in situ hybridization and non-isotopic probes. Dermatology. 184:1992;248-253.
56. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res. 543:1994;4610-4613.
57. Shamanin V, zur Hausen H, Lavergne D, Proby CM, Leigh IM, Neumann C, Hamm H, Goos M, Haustein UF, Jung EG et al. Human paillomavirus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. 1996;J Natl Cancer Inst. p. 802-811.
58. Astori G, Lavergne D, Benton C, Höckmayr B, Egawa K, Garbe C, de Villiers E-M. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol. 110:1998;752-755.
59. Balin AK, Kligman AM. Aging and the Skin. 1989;Raven Press, New York.
60. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 33:1995;690-695.
61. de Villiers E-M, Lavergne D, McLaren K, Benton EC. Prevailing pa pillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer. 73:1997;356-361.
62. Smith. Cutaneous neoplasia in a military population. J Am Acad D ermatol. 3:1993;400-406.
63. Rudlinger R, Grob R. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet i: 1989;1132-1133.
64. Kawashima M, Jablonska S, Favre M, Obalek S, Croissant O, Orth G. Characterization of a new type of human papillomavirus found in a lesion of Bowen's disease of the skin. J Virol. 57:1986;688-692.
65. Stone M, Noonan C, Tschen J. Bowen's disease of the feet: presence of human papillomavirus 16 DNA in tumour tissue. Arch Dermatol. 123:1987;1517-1520.
66. Ostrow RS, Shaver K, Turnquist S, Viksnins A, Bender M, Vance C, Kaye V, Faras AJ. Human papillomavirus-16 DNA in a cutaneous invasive cancer. Arch Dermatol. 125:1989;666-669.
67. Moy R L, Eliezre Y D, Nuovo G J, Zitelli J A, Bennet R G, Silverstien S. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. J Am Med Assoc. 261: 1989;2660-2673.
68. Guitart J, Bergfeld WF, Tuthill RJ, Tubbs RR, Zienowicz R, Fleegler EJ. Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 cases. Br J Dermatol. 123:1990;215-222.
69. McGrae JD Jr, Greer CE, Manos MM. Multiple Bowen's disease of th e fingers associated with human papilloma virus type 16. Int J Dermatol. 32:1993;104-107.
70. Mitsuishi T, Sata T, Matsukura T, Iwasaki T, Kawashima M. The presence of mucosal human papillomavirus in Bowen's disease of the hands. Cancer. 79:1997;1911-1917.
71. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JA, Bird CC. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer. 69:1994;222-229.
72. Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavinck JN, vermeer BJ, van der Wolde FJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 33:1995;690-695.
73. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 79:1992;328-337.
74. Kiviat, N, B, Human papillomavirus, in Manual of Clinical Microbiology, Smith, T, F, ASM Press, Washington, DC.
75. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16. Hum Pathol. 24:1993;432-437.
76. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology. 184:1991;9-13.
77. Scheffner M, Werness BA, Huibregtse JM, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
78. McGregor JM, Berkhout RJ, Rozycka M, ter Schegget J, Bouwes Bavinck JN, Brooks L, Crook T. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene. 15:1997;1737-1740.
79. Harwood CA, Spink PJ, Surentheran T, Leigh IM, Hawke JL, Proby CM, Breuer J, McGregor JM. Detection of human papillomavirus DNA in PUVA- associated non-melanoma skin cancers. J Invest Dermatol: 1998;123-127.
80. Purdie KJ. The promoter of a novel human papillomavirus (HPV 77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J. 18:1999;5359-5369.
81. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 14:1996;841-851.
82. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 272:1996;1668-1671.
83. Gailani MR, Bale AE. Developmental genes and cancer: role of pat ched in basal cell carcinoma of the skin. J Natl Cancer Inst. 89:1997;1103-1109.
84. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, Toftgard R. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet. 14:1996;78-81.
85. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 57:1997;2581-2585.
86. Unden AB, Zaphiropoulos PG, Bruce K, Toftgard R, Stahle-Backdahl M. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res. 57:1997;2336-2340.
87. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, Zhang X, Scott MP, Epstein EH Jr. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 110:1998;885-888.